(Q45774346)

15 December 2017

title

Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells (English)

1 reference

15 December 2017

main subject

endothelium

0 references

author name string

Tatiane C Izidoro-Toledo

1

1 reference

15 December 2017

Danielle A Guimaraes

2

1 reference

15 December 2017

Vanessa A Belo

3

1 reference

15 December 2017

Raquel F Gerlach

4

1 reference

15 December 2017

Jose Eduardo Tanus-Santos

5

1 reference

15 December 2017

publication date

30 March 2011

1 reference

15 December 2017

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

15 December 2017

volume

383

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

547-554

1 reference

15 December 2017

Lipophilic statins prevent matrix metalloproteinase-mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

A comparison of six statins on the development of intimal hyperplasia in a human vein culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

An absolute role of the PKC-dependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Cell cycle-specific effects of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Statins inhibit matrix metalloproteinase release from human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Chitosan oligosaccharides attenuate hydrogen peroxide-induced stress injury in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Nitrosative stress and pharmacological modulation of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Regulation of matrix metalloproteinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00210-011-0623-0

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

21 January 2018

1 reference

12 December 2020

Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity

1 reference

12 December 2020

A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins

1 reference

12 December 2020

Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma

1 reference

12 December 2020

Plasma MMP-9 - a marker of carotid plaque instability

1 reference

12 December 2020

Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

12 December 2020

Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin

1 reference

12 December 2020

Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9

1 reference

12 December 2020

Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

1 reference

12 December 2020

10.1007/S00210-011-0623-0

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

1000638589

0 references

1 reference

15 December 2017